| |
 |
ARTICLES 
|
|
| Cancer prevention |
| J Horton |
|
JCO Jun 1 1985: 747–748.
[PDF]
|
 |
| Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone, 1968-1980 |
| S Hellman |
|
JCO Jun 1 1985: 749–750.
[PDF]
|
|
|
Inhibition of phorbol ester--induced human epidermal ornithine decarboxylase activity by oral compounds: a possible role in human chemoprevention studies |
| |
CL Loprinzi, AK Verma, RK Boutwell, and PP Carbone |
| |
JCO Jun 1 1985: 751–757.
[Abstract]
[PDF]
|
|
|
Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980) |
| |
MA Cornbleet, U Vitolo, JE Ultmann, HM Golomb, D Oleske, ML Griem, DJ Ferguson, and JB Miller |
| |
JCO Jun 1 1985: 758–768.
[Abstract]
[PDF]
|
|
|
Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma |
| |
EZ Ezdinli, JR Anderson, F Melvin, JH Glick, TE Davis, and MJ O'Connell |
| |
JCO Jun 1 1985: 769–775.
[Abstract]
[PDF]
|
|
|
The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia |
| |
SL George, JJ Ochs, AM Mauer, and JV Simone |
| |
JCO Jun 1 1985: 776–781.
[Abstract]
[PDF]
|
|
|
Adult T cell leukemia with atypical surface phenotypes: clinical correlation |
| |
Y Yamada, S Kamihira, T Amagasaki, K Kinoshita, M Kusano, S Chiyoda, E Yawo, S Ikeda, J Suzuyama, and M Ichimaru |
| |
JCO Jun 1 1985: 782–788.
[Abstract]
[PDF]
|
|
|
Etoposide (VP-16) with prednisone and vincristine for the treatment of refractory acute lymphoblastic leukemia |
| |
M Abromowitch, WP Bowman, J Ochs, and G Rivera |
| |
JCO Jun 1 1985: 789–792.
[Abstract]
[PDF]
|
|
|
A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia |
| |
HM Kantarjian, MJ Keating, KB McCredie, M Beran, R Walters, WT Dalton, Jr, W Hittleman, and EJ Freireich |
| |
JCO Jun 1 1985: 793–798.
[Abstract]
[PDF]
|
|
|
DNA-RNA measurements in patients with acute leukemia undergoing remission induction therapy |
| |
AM Maddox, DA Johnston, B Barlogie, E Youness, M Keating, and EJ Freireich |
| |
JCO Jun 1 1985: 799–808.
[Abstract]
[PDF]
|
|
|
Iodine 125 suture implants in the management of advanced tumors in the neck attached to the carotid artery |
| |
SB Paryani, DR Goffinet, WE Fee, Jr, RL Goode, P Levine, and ML Hopp |
| |
JCO Jun 1 1985: 809–812.
[Abstract]
[PDF]
|
|
|
Treatment of nasopharyngeal carcinoma with human leukocyte interferon |
| |
JM Connors, WA Andiman, CB Howarth, E Liu, TC Merigan, ME Savage, and C Jacobs |
| |
JCO Jun 1 1985: 813–817.
[Abstract]
[PDF]
|
|
|
A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer |
| |
KK Jain, ES Casper, NL Geller, TB Hakes, RJ Kaufman, V Currie, W Schwartz, C Cassidy, GR Petroni, and CW Young |
| |
JCO Jun 1 1985: 818–826.
[Abstract]
[PDF]
|
|
|
A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma |
| |
MA Eisenberger, R Simon, PJ O'Dwyer, RE Wittes, and MA Friedman |
| |
JCO Jun 1 1985: 827–841.
[Abstract]
[PDF]
|
|
|
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer |
| |
JE Krook, JR Jett, TR Fleming, RJ Dalton, RF Marschke, SA Cullinan, HE Windschitl, LK Everson, FS Brunk, and JA Laurie |
| |
JCO Jun 1 1985: 842–848.
[Abstract]
[PDF]
|
|
|
Pharmacokinetics of 5-fluorouracil during hyperthermic pelvic isolation- perfusion |
| |
AG Wile, EA Stemmer, PA Andrews, MP Murphy, IS Abramson, and SB Howell |
| |
JCO Jun 1 1985: 849–852.
[Abstract]
[PDF]
|
|
|
Phase I trial of N-methylformamide (NMF, NSC 3051) |
| |
PJ O'Dwyer, M Donehower, LM Sigman, CL Fortner, J Aisner, and DA Van Echo |
| |
JCO Jun 1 1985: 853–857.
[Abstract]
[PDF]
|
|
|
Extraskeletal mesenchymal chondrosarcoma: case report and review of the literature |
| |
C Louvet, A de Gramont, M Krulik, M Jagueux, D Hubert, P Brissaud, A Sirinelli, B Augereau, JM Tubiana, and J Debray |
| |
JCO Jun 1 1985: 858–863.
[Abstract]
[PDF]
|
|
|
Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects |
| |
J Laszlo, RA Clark, DC Hanson, L Tyson, L Crumpler, and R Gralla |
| |
JCO Jun 1 1985: 864–869.
[Abstract]
[PDF]
|
|
|
Criteria of tumor response used in clinical trials of chemotherapy |
| |
K Tonkin, D Tritchler, and I Tannock |
| |
JCO Jun 1 1985: 870–875.
[Abstract]
[PDF]
|
|
| Tumor-associated antigens--an overview |
| JR Zalcberg and IF McKenzie |
|
JCO Jun 1 1985: 876–882.
[PDF]
|
|
| Population-based study of small-cell lung cancer |
| SK Carter |
|
JCO Jun 1 1985: 883–884.
[PDF]
|
|
| Biliary sclerosis and the implanted pump |
| AJ Weiss |
|
JCO Jun 1 1985: 884a.
[PDF]
|
|
| Management of pathologic stage IIIA Hodgkin's disease |
| NE Sherman |
|
JCO Jun 1 1985: 884b–885.
[PDF]
|
|
| Leukemia following treatment of germ cell tumors in men |
| J Pedersen-Bjergaard, M Rorth, NI Nissen, and P Philip |
|
JCO Jun 1 1985: 885–887.
[PDF]
|
|
| FAM therapy for advanced gastric cancer: an ideal standard? |
| SA Cullinan and CG Moertel |
|
JCO Jun 1 1985: 887–889.
[PDF]
|
|
| Dose intensity in chemotherapy of metastatic breast cancer |
|
|
JCO Jun 1 1985: 889–891.
[PDF]
|
|
